U.S. Markets closed

aTyr Pharma, Inc. (LIFE)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
3.40-0.15 (-4.23%)
At close: 4:00PM EDT
People also watch
QGENILMNPKIXRAYNWSA
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development42,84634,50416,777
Selling General and Administrative15,09413,1126,777
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-57,940-47,616-23,554
Income from Continuing Operations
Total Other Income/Expenses Net-292936
Earnings Before Interest and Taxes-57,904-47,973-24,350
Interest Expense---
Income Before Tax-57,904-47,973-24,350
Income Tax Expense-49--
Minority Interest---
Net Income From Continuing Ops-57,855-47,973-24,350
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-57,855-47,973-24,350
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-57,855-47,988-24,766